Main Management ETF Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
17,776
+440
+3% +$29.3K 0.04% 86
2026
Q1
$1.09M Buy
+17,336
New +$1.21M 0.04% 93

Other funds holding DXCM

Main Management ETF Advisors's DXCM Position: Q2 2026 in Review

Main Management ETF Advisors increased its DexCom (DXCM) stake by 2.5% in Q2 2026, buying an estimated $29.3K and bringing the position to 17,776 shares worth $1.2M. The position accounts for 0.04% of the portfolio, ranked #86.

Main Management ETF Advisors first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Main Management ETF Advisors held 17,776 shares of DexCom worth $1.2M as of Q2 2026.
  • Main Management ETF Advisors bought 440 DexCom shares in Q2 2026, an estimated $29.3K.
  • DexCom made up 0.04% of Main Management ETF Advisors's portfolio in Q2 2026, its #86 holding.
  • Main Management ETF Advisors first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Main Management ETF Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.